Angiopoietin-like protein 3 promotes preservation of stemness during Ex Vivo expansion of murine hematopoietic stem cells by Farahbakhshian, E. (Elnaz) et al.
Angiopoietin-Like Protein 3 Promotes Preservation of
Stemness during Ex Vivo Expansion of Murine
Hematopoietic Stem Cells
Elnaz Farahbakhshian1,2, Monique M. Verstegen1,3, Trudi P. Visser1, Sima Kheradmandkia4, Dirk Geerts2,
Shazia Arshad1, Noveen Riaz1, Frank Grosveld4, Niek P. van Til1, Jules P. P. Meijerink2*
1 The Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands, 2 The Department of Pediatric Oncology/Hematology, Erasmus Medical Center,
Rotterdam, the Netherlands, 3 The Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands, 4 The Department of Cell Biology, Erasmus Medical
Center, Rotterdam, the Netherlands
Abstract
Allogeneic hematopoietic stem cell (HSC) transplantations from umbilical cord blood or autologous HSCs for gene therapy
purposes are hampered by limited number of stem cells. To test the ability to expand HSCs in vitro prior to transplantation,
two growth factor cocktails containing stem cell factor, thrombopoietin, fms-related tyrosine kinase-3 ligand (STF) or stem
cell factor, thrombopoietin, insulin-like growth factor-2, fibroblast growth factor-1 (STIF) either with or without the addition
of angiopoietin-like protein-3 (Angptl3) were used. Culturing HSCs in STF and STIF media for 7 days expanded long-term
repopulating stem cells content in vivo by ,6-fold and ,10-fold compared to freshly isolated stem cells. Addition of
Angptl3 resulted in increased expansion of these populations by ,17-fold and ,32-fold, respectively, and was further
supported by enforced expression of Angptl3 in HSCs through lentiviral transduction that also promoted HSC expansion. As
expansion of highly purified lineage-negative, Sca-1+, c-Kit+ HSCs was less efficient than less pure lineage-negative HSCs,
Angptl3 may have a direct effect on HCS but also an indirect effect on accessory cells that support HSC expansion. No
evidence for leukemia or toxicity was found during long-term follow up of mice transplanted with ex vivo expanded HSCs or
manipulated HSC populations that expressed Angptl3. We conclude that the cytokine combinations used in this study to
expand HSCs ex vivo enhances the engraftment in vivo. This has important implications for allogeneic umbilical cord-blood
derived HSC transplantations and autologous HSC applications including gene therapy.
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Introduction
Hematopoietic stem cells (HSCs) have the ability to self-renew
and to give rise to cells of all blood lineages. This makes HSCs a
valuable source for treatment of patients with genetic blood
disorders through cell- or gene-based therapies [1–4]. These
therapies are restricted by the limited availability of suitable,
human leukocyte antigen (HLA)-matched donors. Additionally, if
autologous cells for genetic modification are concerned, limited
numbers of cells can be retrieved per patient. Umbilical cord blood
(UBC) potentially provides an alternative and abundant source of
donor HSCs, if the number of HSCs could be increased in vitro
[5,6]. Optimization of in vitro expansion protocols would
therefore facilitate successful transplantations using UCB-derived
HSCs or genetically-modified autologous HSCs [7,8].
Early attempts to expand HSC in vitro resulted in a preferential
expansion of committed progenitor cells without preserving
stemness, resulting in defective long term hematopoiesis [9].
However, the knowledge on hematopoietic stem cell expansion has
increased, and new methods for promoting expansion of stem cells
while retaining stemness have been developed. Ectopic expression
of the transcription factors, such as homeobox B4 (HoxB4) or
apoptotic regulators such as Bcl-2 have been investigated and can
result in robust HSC expansion [10,11]. However, the long term
consequences of constitutive activation of anti-apoptotic pathways
triggered by specific factors such as Bcl-2 or HoxB4 is not yet fully
investigated. Another obstacle is the delivery of these proteins,
which may require vector-based vehicles, which should be efficient
and not genotoxic [12–15]. To circumvent these problems, it
would therefore be preferable to develop methodology to expand
HSC without the introduction of foreign DNA sequences.
Several growth factors have been identified over the years that
enhance the self-renewal capacity of mouse HSCs, including
ligands for various pathways such as Notch1 [16], stem cell factor
(SCF) [17], thrombopoietin (TPO) [18,19], fms-like tyrosine
kinase-ligand (Flt3-L) [20], fibroblast growth factor (FGF-1)
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[21,22] or WNT-pathway factors like Wnt3a [23]. The Lodish
group identified a fetal liver stromal cell population that produces
high levels of insulin growth factor-2 (IGF-2) and angiopoietin-like
proteins in addition to SCF and delta-like NOTCH1 ligands.
These factors were shown to support HSC expansion in vivo [24–
26]. The combination of IGF-2, angiopoietin-like 2 (Angptl2), and
angiopoietin-like 3 (Angptl3) growth factors also support HSC
expansion in vitro [25,26]. Various studies support a pivotal role
for Angptl3 in regulating HSC self-renewal capacity [26–29]. This
was confirmed by results from the Angptl3 knock-out mouse
model that demonstrate reduced numbers of quiescent HSCs as
well as reduced repopulation capacity in transplantation experi-
ments [27]. Angptl3 is expressed by endothelial and other stromal
cells in the bone marrow and binds as an extrinsic factor to
receptors on HSCs [27]. At present, the receptor for Angptl3 is not
clear as the immune-inhibitory receptor human leukocyte
immunoglobulin-like receptor B2 (LILRB2) and the mouse
orthologue paired immunoglobulin-like receptor (PIRB) have
been identified as receptors for several angiopoietin-like proteins
(Angptls) including Angptl2, 25, and 27, but this is unclear for
Angptl3 [28]. Binding of Angptls to its receptor results in reduced
expression of Ikaros and activate self-renewal capacity [27].
Overexpression of Ikaros in HSCs was shown to diminish
repopulation capacity [27]. The combination of saturated levels
of SCF, TPO, IGF2, FGF1 and Angptl3 has been proven as a
suitable cocktail that promotes expansion of long-term repopulat-
ing HSCs (LT-HSCs) numbers up to ,30-fold [26].
In the present study, we tested the preservation and expansion
of long- and short-term HSCs in vitro in serum-free culture
conditions in the presence of SCF, TPO, IGF2 and FGF-1 (STIF)
[26] or SCF, TPO and FLT3-L (STF) [9]. Long-term repopulat-
ing capacity was investigated for cultured HSCs under various
conditions followed by transplantation into sub lethally irradiated
mice. We investigated a potential additive effect of mAngptl3, that
may exert a direct effect on HSCs. We also tested the potential




Female a-thalassemic BALB/c mice between 8 to 12 weeks of
age were used as bone marrow (BM) recipients, and healthy male
littermates were used as donors for HSCs. Mice were bred and
housed under specific pathogen free (SPF) conditions at the
Experimental Animal Facility of Erasmus Medical Center
(Rotterdam, the Netherlands). All experiments have been
approved by the local ethical committee for animal experiments
and are in accordance with national legislation.
Stem cell isolation
Lineage negative (Lin2) cells were purified from BM using the
BD IMag Mouse Hematopoietic Progenitor Cell Enrichment Set
(BD Biosciences, Breda, The Netherlands) according to the
manufacturer’s instructions. HSC were further enriched from
the Lin2 cell population by sorting Sca-1+/c-kit+ (LSK) cell
populations using a BD FACS Aria flow cytometry (BD
Biosciences). For this, Lin2 cells were incubated with c-kit–
allophycocyanin (APC; BD Biosciences) and Sca-1–R-phycoery-
thrin (PE; BD Biosciences), and washed once with Hank’s solution
supplemented with HEPES (300 mOsm) prior to sorting.
Construction of lentiviral vector plasmids
A codon optimized m-Angptl3 cDNA (Genscript) was devel-
oped and excised from plasmid pUC57-m-Angptl3 by SalI and
XmaI digestion, and cloned into the third generation pCCLsin-
cppt-SV40polyA-eGFP-minCMV-hPGK-WPRE lentiviral (LV-
GFP) vector [30] to generate the pCCLsin-cppt-SV40polyA-
eGFP-minCMV-hPGK- mAngptl-3-WPRE vector. This bidirec-
tional vector drives expression of both Angptl3 and eGFP, and will
be denoted as LV-Angptl3-GFP.
Production of lentiviral vectors
Lentiviral (LV) particle production was done by transfecting the
LV-Angptl3-GFP vector in combination with pMDL-g/pRRE,
pMD2-VSVg and pRSV-Rev helper plasmids into HEK 293T
cells using standard calcium phosphate as previously described
[31,32]. Lentiviral particles were concentrated through ultracen-
trifugation for 2 hours at 20,000 rpm and collected at 4uC. The
multiplicity of infection (MOI) of LV-Angptl3-GFP or LV-GFP
was determined on HeLa cells by serial dilution, and the
percentage of eGFP-positive cells was estimated by flow cytometry.
Angptl3 protein expression was detected by a standard Western-
blot procedure using the mouse monoclonal anti-ANGPTL3
(1D10) antibody (Novus Biologicals, Cambridge, United King-
dom).
In vitro suspension culture
Fresh Lin2 or LSK cells were cultured in 24-well plates (Costar
tissue-culture treated polystyrene, Corning, Corning, NY, USA) at
a density of 4–66104/ml in enriched serum-free Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 1% (wt/
vol) bovine serum albumin (BSA), 0.3 mg/L human transferrin,
0.1 mM sodium selenite, 1 mg/L nucleosides (cytidine, adenosine,
uridine, guanosine,29-deoxycytidine, 29-deoxyaenosine, thymidine
and 29-deoxyguanosine; Sigma, St. Louis, MO, USA), 0.1 mM ß-
mercaptoethanol, 15 mM linoleic acid, 15 mM cholesterol, 100 U/
ml penicillin and 100 mg/ml streptomycin as described previously
[33,34]. The enriched DMEM medium was supplemented with
murine SCF (50 ng/ml, R&D, Abingdon, UK), murine TPO
(20 ng/ml, R&D), murine IGF2 (20 ng/ml, R&D), human FGF-1
(10 ng/ml, R&D) and heparin (10 mg/ml, Sigma) and will be
further denoted as STIF medium [26]. Alternatively, enriched
DMEM medium was supplemented with murine SCF (50 ng/ml,
R&D), murine TPO (20 ng/ml, R&D) and human FLT3-L
(50 ng/ml, R&D) and is further denoted as STF medium [9]. Both
STIF and STF media were supplemented with murine Angptl3
(200 ng/ml, R&D) and will be referred to as STFA3 or STIFA3
media, respectively. All cells were maintained at 37uC in a
humidified incubator at 10% CO2 levels.
Lentiviral hematopoietic stem cell transduction and
sorting
Lin2 donor cells were transduced overnight with LV-Angptl3-
GFP or the LV-GFP at a cell density of 106 cells/ml using a MOI
of 10. During this transduction procedure, cells were maintained
in serum-free DMEM medium that was supplemented with
various growth factors including murine SCF (100 ng/ml, R&D),
murine TPO (20 ng/ml, R&D) and murine IGF-2 (20 ng/ml,
R&D). The following day, cells were diluted to 56104 cell/ml and
cultured for another 24 hrs. Subsequently, Lin2 GFP+ cells were
flow-sorted with a purity of .90%. Sorted cells were used in
experiments directly or following preculturing in STIF media. All
of the cells were incubated at 10% CO2 levels and 37uC.
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In vitro clonogenic progenitor assays
Frequencies of HSCs and progenitor cells were estimated using
semi-solid colony assays. For this, freshly sorted or cultured
(transduced) Lin2 (26103) or LSK (0.26103) cells were plated in
35 mm culture dishes (BD BioCoat Collagen IV, tissue-culture
treated polystyrene) that contained 1 ml of enriched DMEM
culture medium that was supplemented with 0.8% (wt/vol)
methylcellulose (Methocel A4M Premium Grade, Dow Chemical,
Barendrecht, The Netherlands) as described [33,35]. All primary
data is shown in table S1 and S2.
For colony- forming unit granulocyte-macrophage (CFU-GM)
differentiation assays, Lin2/LSK cells were cultured in methyl-
cellulose-enriched DMEM medium that was further supplemented
with 10 ng/ml mouse interleukin-3 (mIL-3), 100 ng/ml m-SCF
and 20 ng/ml granulocyte macrophage colony- stimulating factor
(GM-CSF). For burst-forming erythroid unit (BFU-E) assays,
Lin2/LSK cells were incubated in methylcellulose-enriched
DMEM medium that was supplemented with 100 ng/ml m-SCF
and 4 U/ml human erythropoietin (H-EPO, Behringwerke,
Marburg, Germany). Cells were maintained for 14 days prior to
microscopic analysis and the total numbers of colonies were
counted. Each experiment was carried out in duplicate.
Colony forming unit spleen (CFU-S)
Lin2 or LSK donor cells were transplanted into lethally
irradiated (8 Gy) BALB/c female recipient mice (n = 6–10 per
group). A total of 1,000 or 3,000 of freshly isolated Lin2 cells were
transplanted or equivalents of 100 or 1,000 cells that were cultured
for 4 to 7 days in STF, STFA3, STIF or STIFA3 media. For LSK
cell transplantation, a total of 30 or 100 freshly isolated LSK cells
were transplanted directly or following culture for 7-days in STF,
STFA3, STIF or STIFA3 media. For LSK cell transplantations,
1000 irradiated non-selected BM cells (50 Gy) were co-transplant-
ed to improve homing. No splenic colonies were observed in
control mice that were transplanted with 1000, 50 Gy- irradiated
BM cells only. All primary data is shown in table S1 and S2.
In addition, Lin2 cells were transduced with LV-GFP or LV-
Angptl3-GFP. The GFP+ population was sorted 2 days after
transduction, and 1000 Lin2 GFP+ cells were intravenously
transplanted into lethally irradiated (8 Gy) BALB/c recipients
(n = 7–10 mice per group). Twelve days after transplantation, mice
were sacrificed and the spleens were incubated in fixation buffer
(70% ethanol supplemented with 5% acetic acid and 2%
formalin). The number of spleen colonies (CFU-S) was counted.
Long-term repopulation ability assay (LTRA)
Lin2 or LSK male donor cells were transplanted into sub-
lethally irradiated (6 Gy) female a-thalassemia mice. Blood was
collected monthly for six months following transplantation, and
blood cell counts were measured with a Vet Animal Blood
Counter hematology analyzer (Scil Animal Care Company
GmbH). Red blood cell (RBC) chimerism were measured
following preparation of mouse peripheral blood in 1 ml 0.6%
NaCl buffer, and then populations of microcytic thalassemia RBCs
and healthy RBCs were determined by flow cytometry (FACS
Calibur, BD Biosciences). Percentage of chimerism was calculated
using the following formula: [20.6+SQUART((0.62–
460.0026(10.43-donor cells %)))/0.004] [36].
In another experiment, donor Lin2 cells were transduced with
control LV-GFP or LV-Angptl3-GFP. GFP+ cells were sorted 2
days after transduction as described above. Lin2, GFP+ cells
(10,000 cells) were transplanted into sub lethally irradiated (6 Gy)
female a-thalassemia recipient mice. Blood was collected at one,
four, six and nine months following transplantation to determine
the percentages of GFP+ peripheral blood cells. Similarly,
percentages of GFP+ white blood cell types in BM or spleens
were measured 9 months after transplantation, using antibodies
against Sca-1, c-Kit, CD4, CD8, CD19, and CD11b (Miltenyi
Biotec, BD Biosciences).
Y-chromosome Q-PCR
Y-chromosome Q-PCR was performed to detect the percentage
of donor leukocyte chimerism in recipient mice following
transplantation. DNA was extracted from BM using a DNeasy
Blood & Tissue Kits (Qiagen, Germany). Specific primers for the
Sry locus in the Y-chromosome were designed using Beacon
software (New Orleans, LA, USA): Sense primer, 59-TCA-TCG-
GAG-GGC-TAA-AGT-GTC-AC-39; antisense primer, 59-TGG-
CAT-GTG-GGT-TCC-TGT-CC-39. As a control for total DNA,
the following GAPDH primers were used: sense primer 59-ACG-
GCA-AAT-TCA-ACG-GCA-CAG-39; antisense primer, 59-ACA-
CCA-GTA-GAC-TCC-ACG-ACA-TAC-39. Each reaction mix-
ture contained 8 ml of DNA template (70 ng), 8 ml SYBR Green
PCR Master Mix (Applied Biosystems, Foster City, CA)
and1.25 ml of each primer (5 ng/ml) in a final reaction volume
of 25 ml. Q-PCR was performed in a Biorad MyiQ thermocycler
as follows: 95uC for 3 min, followed by 40 cycles of 95uC for 15
seconds and 60uC for 45 seconds.
Statistical analysis
Data are expressed as the mean 6 standard deviation (SD).
Statistical significance between nominal data point comparisons
was determined using the Mann-Whitney-U test. Standard
deviations of colony counts were calculated on the assumption
that crude colony counts show a normal Poisson distribution.
Results
The effect of Angptl3 on ex vivo expansion and
differentiation capacity of murine hematopoietic stem
cells
The expansion of murine hematopoietic stem cell (HSC) was
tested using various media conditions; Lin2 or purified LSK cells
were cultured ex vivo in media supplemented with STF, STFA3,
STIF or STIFA3 growth factor cocktails (see materials and
methods). Culturing LSK cells for 7 days in STF- or STIF- media
led to ,35-fold expansion in total cell number (Figure 1A). The
LSK phenotype was best preserved in STIF media (at a level of
4563%) compared to STF media (at 3064%) (Figure 1B).
Addition of mAngptl3 did not result in significant increases in
the preservation of LSK phenotype during expansion. The
expansion rate of Lin2 cells also did not differ between STF or
STIF media (Figure S1A). Again, supplementing the media with
Angptl3 did not result in a significant increase in total cell
numbers. Culturing Lin2 cells in STFA3 media for ten days
resulted in a near 60-fold expansion of total cell numbers.
We next tested the differentiation capacity of in vitro expanded
hematopoietic progenitor cells by carrying out various colony-
forming unit assays on Lin2 cells (Figure S1B-C) or sorted LSK
cells cultured in STF, STFA3, STIF or STIFA3 media (Figur-
es 1C and 1D). BFU-Es colony forming units were boosted 1161
fold for LSK cells cultured in STF and STIF media for 7 days
compared to non-cultured LSK cells (Figure 1C). Addition of
Angptl3 significantly increased the total number of colony forming
units 1661 and 1561 fold for STFA3 and STIFA3 media,
respectively. For granulocyte- macrophage progenitor cells,
culturing in STF or STIF media for 7 days expanded the number
of CFU-GM colonies by 9-fold and 7-fold, respectively. Again,
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culturing with Angptl3-supplemented media further increased the
number of CFU-GM colonies to 1362 and 1461 fold using
STFA3 and STIFA3 media, respectively (Figure 1D). Similar
results were obtained from the number of BFU-E and CFU-GM
colony forming units in the Lin2 subset (Figures S1B–C).The
colony forming unit spleen assay (CFU-S) was used to assess the
effect of Angptl3 on short-term HSC (ST-HSC) in Lin2 and LSK
cells (Figure 1E, Figure S1D). LSK cells pretreated in STF or
STIF media showed a 2862 and 3062 fold increase in splenic
colonies, respectively. Culturing LSK cells in STFA3 or STIFA3
media boosted CFU-S colony formation to 3864 and 3763-fold
relative to control mice. In case of STFA3 the increase was
significantly higher relative to STF.
Effect of Angptl3 on long-term HSCs expansion from LSK
cells
We next investigated whether culturing of HSCs in the presence
of Angptl3 would potentiate long-term hematopoiesis in vivo.
Long-term repopulating ability (LTRA) assays were performed by
transplanting sorted male Lin2 (3000, 1000 or 300 cells) or LSK
cells (200 cells) into sub-lethally irradiated female a-thalassemia
mice with or without prior culturing in STF, STFA3, STIF or
STIFA3 media for 7 days (Figure 2A, Figure S2). Near full donor
engraftment at 7 months following transplantation of LSK cells
was identified in the BM and PB compartments of mice regardless
of prior incubation conditions (Figure 2A). One million BM cells
from these primary transplanted mice were then retransplanted
into secondary recipients, and these mice remained healthy for
over 6 months without any symptoms of disease. The percentage
of erythrocyte chimerism in the peripheral blood of secondary
recipients that received uncultured LSK cells was 43%. However,
culturing of the LSK cells prior to transplantation in the first
recipient using STF or STIF media increased chimerism levels to
6063% and 6565% in the secondary transplanted mice,
respectively. Incubation with Angptl3-containing media further
increased chimerism levels for STFA3 and STIFA3 media to
7464% and 7764% respectively (Figure 2B). The percentages of
leukocyte chimerism—established by Y-chromosomal QPCR in
bone marrow samples—was similar to the pattern of RBC
chimerism levels in peripheral blood in these mice. To quantify
the differentiation capacity of cultured LSK cells compared to
freshly sorted LSK cells, primary recipient mice were transplanted
with 12 or 120 LSK donor cells directly or with offspring cells from
12 or 120 LSK cells following a 7 day culture in STF, STFA3,
STIF or STIFA3 media. Transplanting 12 freshly-isolated LSK
Figure 1. The effect of Angptl3 on progenitors and ST-HSCs in LSK cell populations. Lin2 Sca-1+ c-kit+ (LSK) cells were cultured in STF or
STIF media with or without Angptl3 for 7 days. (A) The mean fold increase in total cell numbers was measured in comparison to day 0. The results of
five independent duplicate experiments are shown. (B) LSK cells were cultured for 7 days, and Sca-1 and c-kit markers were determined by flow
cytometry. (C) BFU-E and (D) CFU-GM colony forming-units of LSK cells cultured for 7 days are shown relative to fresh LSK cells. The results of five
independent experiments are shown. (E) The CFU-S (12-day) fold expansion of LSK cells cultured for 7 days in STF or STIF media with or without
Angptl3 relative to fresh LSK cells. For each group, splenic colonies of 6 mice were counted. The results of two independent experiments are shown.
Data is presented 6 standard deviation (SD), *P#0.05.
doi:10.1371/journal.pone.0105642.g001
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cells let to a 2564% donor erythrocyte chimerism level in the
peripheral blood 6 months after transplantation (Figure 2C).
Culturing of 12 LSK cells in STF or STIF media prior to primary
transplantation resulted in donor erythrocyte chimerism of
3765% or 4064% in secondary transplanted mice, respectively.
Culturing 12 LSK cells in STFA3 or STIFA3 media reconstituted
4864 and 5665% of donor erythrocyte chimerism levels,
respectively. Again, leukocyte chimerism in the bone marrow
phenocopied erythrocyte chimerism levels in peripheral blood of
primary transplanted mice. Based on the results from the serial
dilution transplantation experiment, culturing LSK cells in STF or
STIF media prior to transplantation enhanced ,10 or ,6-fold
long-term repopulation activity of HSCs. Culturing LSK cells in
presence of Angptl3 enhanced number of LT-HSC ,3-fold,
therefore STFA3 and STIFA3 media resulted in ,17- and ,32-
fold increase in long-term repopulation activity of HSCs compared
to non-pretreated LSK cells, respectively (Figure 2D). For Lin2
ells, culturing in STF media significantly increased erythrocyte
chimerism that was already visible 1 month after transplantation,
and became more evident 6 months after transplantation. These
results also demonstrated that 7 day culture period seems most
optimal. Again, addition of Angptl3 further increased erythrocyte
chimerism levels as well as leukocyte chimerism levels (Figures S2A
and S2B). Based on these limiting dilution transplantation
experiments, we conclude that culturing HSCs in STF media for
7 days increased long-term repopulation capacity ,10-fold, and
was increased by .300-fold for STFA3-incubated Lin2 cells
(Figure S2C).
The effect of Angptl3 on ex vivo expansion and
differentiation capacity of Lin2 cells is direct
To further show that Angptl3 promotes expansion and
reconstitution of HSCs, Angptl3 was ectopically expressed in
Lin2 hematopoietic progenitors by a lentiviral vector with GFP
(LV-Angptl3-GFP). As a control, Lin2 cells were transduced with
a control vector solely expressing GFP (LV-GFP). Western blotting
showed that sorted cells expressed the Angptl3 protein 2 days after
transduction with LV-Angptl3-GFP whereas the control cells
remained negative (Figure 3A). Sorted, transduced cells were then
cultured in STIF media and cell numbers were counted after 4 and
7 days. Expression of Angptl3 resulted in a significant increase in
cell numbers (Figure 3B), and preservation of progenitor cells and
ST-HSCs compared to control cells as assessed by BFU-E and
CFU-GM assays (Figure 3C) or CFU-S assay (Figure 3D),
respectively.
We then assessed the reconstitution capacity of long-term
hematopoiesis for Lin2 cells using long- term repopulation ability
assays (LTRA). For this, 10,000 sorted, male Lin2 GFP+ cells were
transduced with the control LV-GFP or LV-Angptl3-GFP vector
and transplanted into female a-thalassemia recipient mice. All
mice remained healthy for over 9 months, and none of these mice
exhibited tumor growth or elevated WBC counts. One month
post-transplantation, we detected less than 2% GFP+cells in the
Figure 2. Angptl3 augments the expansion of LT-HSCs from LSK cells. (A) Two hundred LSK cells (equivalent to day 0), either fresh or
cultured for 7 days under STF, STFA3, STIF, or STIFA3 conditions, were transplanted into sub lethally irradiated recipients. The percent of erythrocyte
chimerism in PB and leukocyte chimerism in BM was determined 7 months after transplantation. (B) At 7 months post-transplantation, 106 BM cells
from primary recipients were transplanted into secondary recipients, and 6 months after re-transplantation, the percentage of erythrocyte in PB and
leukocyte chimerism in BM of secondary recipients was determined. (C) Six months post- transplantation of 12 LSK cells into primary recipients, the
percentage of erythrocyte chimerism in PB and leukocytes chimerism in BM was determined. (D) Serial dilution of LSK cells (120 or 12 cells)
transplanted into primary recipients. The data represents erythrocytes chimerism of 120 or 12 LSK transplanted cells after 6 months. For all
experiments shown, each group is the combined result of 5 mice. Data is presented 6 standard deviation (SD), **P#0.01.
doi:10.1371/journal.pone.0105642.g002
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peripheral blood of mice that were transplanted with LV-Angptl3-
GFP-transduced Lin2 cells when compared to ,8% in mice
transplanted with the control LV-GFP-transduced Lin2 cells
(Figure 4A). Over the following 8 months, the percentage of GFP+
cells in the LV-GFP control group remained stable and varied
between 6.5–8%. The percentage of GFP+ cells in recipients that
were transplanted with LV- Angptl3-GFP-transduced Lin2 cells
increased over months to 1362% nine months after transplanta-
tion. Percentages of GFP+ cells were also significantly elevated in
the bone marrow of these mice (2363%) compared to control
mice (1562%) (Figure 4B). Hematopoietic differentiation was also
measured in GFP+ cells in the peripheral blood, bone marrow and
spleen compartments (Figures 4C–D–E). In the BM and PB, the
LV-Angptl3-GFP group contained more GFP+ cells with Sca-1+
and Sca-1+/c-kit+ stem cell markers than the LV-GFP control
group. Thus Angptl3 may preserve the immature state of HSCs in
vivo. No difference was observed for the percentage of mature
CD4+ or CD8+ T cells or CD11b+ myeloid cells within the GFP+
population, but the percentage of CD19+ B cells was significantly
decreased in the LV-Angptl3-GFP group compared to the control
group.
We next sorted Lin2, GFP+ cells from BM pools of recipient
mice that were transplanted with LV- Angptl3-GFP or LV-GFP-
transduced Lin2 cells nine months before, and performed
progenitor- and short-term colony forming assays. No significant
difference in the frequency of BFU-E progenitor cells was
identified in the BM Lin2, GFP+ cell population from both
groups (,12 vs. ,10 BFU-E colonies/26103 Lin2, GFP+ cells),
respectively (Figure 5A). However, the number of CFU-GMs was
significantly higher for mice transplanted with LV-Angptl3-GFP-
transduced Lin2 cells relative to the control mice (3161.6 vs.
2162 CFU-GM colonies/26103 Lin2 GFP+) (Figure 5B). In
addition, the number of ST-HSCs was 2 fold higher for the LV-
Angptl3-GFP group compared to the LV-GFP control group (761
vs. 361 CFU-S/103 BM Lin2, GFP+ cells, respectively)
(Figure 5C).
Discussion
Over the past two decades, many attempts have been made to
increase the quantity of long-term HSCs by in vitro culturing
conditions. Although sufficient HSCs are obtained from donors for
conventional bone marrow transplantations, expansion of HSC
may become more and more relevant for transplantations relying
on umbilical cord blood HSCs or transplantation of limiting,
genetically-modified HSCs. Serum free expansion cultures of
HSCs using SCF, TPO and Flt3L-supplemented media (STF)
were shown to maintain the number of murine long term HSCs
but led to increased numbers of human primitive hematopoietic
progenitors with preserved engraftment potential [9,37,38]. Zhang
et al. reported a new combination of growth factors that included
SCF, TPO, IGF-2 and FGF-1 (STIF) that was supplemented with
angiopoietin-like protein 2 or 3 (Angptl2, Angptl3) that supported
ex-vivo expansion of murine long-term HSC frequencies by 24- to
30-fold in 10 days [26,27]. Furthermore, IGF- binding protein 2
(IGFBP2) and Angptl5 (A5) were introduced as additional factors
that support human HSC expansion [39]. Using SCF [40], TPO
Figure 3. Angptl3 overexpression promotes expansion of HSCs in Lin2 cell populations. (A) Western blotting analysis for Angptl3
expression in sorted Lin2 GFP+ cells 2 days following transduction with LV-Angptl3-GFP or the mock control LV-GFP lentiviral particles. (B) Total cell
fold expansion and (C) fold increase in BFU-E or CFU-GM progenitor colonies from transduced Lin2 GFP+ cells as described under (A) that were
cultured for 4 or 7 days. Results are shown relative to day 0, transduced sorted Lin2 cells. Mean values are obtained from 5 independent experiments.
(D) Short-term colony forming unit assay (CFU- S). Lin2 GFP+ cells were sorted 2 days post transduction and immediately transplanted into lethally
irradiated mice. Total numbers of CFU-S colonies in the spleen were counted after 12 days following transplantation (N= 10 mice). *P#0.05.
doi:10.1371/journal.pone.0105642.g003
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Figure 4. Angptl3 overexpression stimulates the expansion of LT-HSCs in Lin2 cell populations in vivo. (A) Ten thousand sorted BM
Lin2 Angptl3-GFP+ or BM Lin2 GFP+ cells were transplanted into sub lethally irradiated recipients. The percentage of donor-derived cells (GFP+) was
determined at 1, 4, 6, and 9 month(s) after transplantation in PB. N= 5 mice per group. The error bars indicate the standard deviation (SD). (B) The
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[41], and FGF-1 supplemented with IGFBP2 and Angptl5, the
number of human stem cells that can repopulate NOD-SCID
mice increased ,20-fold compared to non- cultured HSCs [42].
In recent years, other factors have been identified that support
in vitro expansion of HSCs. These stimulate the Wnt [43] and
Notch [44] pathways that have been implicated in the regulation
of HSCs fate [45]. Wnt signaling may inhibit glycogen synthase
kinase 3 (GSK-3) thereby stabilizing b-actin that supports
expansion of HSCs. However, inhibition of GSK-3 also results
in the upregulation of the mammalian target of rapamycin
(mTOR), which promotes the proliferation of committed progen-
itor cells. It was shown that a dual inhibitor for both GSK-3 and
mTOR resulted in maintenance and expansion of HSCs in vitro,
even in the absence of cytokines [45]. Microenvironmental factors
such as pleiotrophin may also enhance HSC expansion in vitro
and improved HSC repopulating capacity by ,10-fold using
competitive transplantation assays [46]. Chemical compounds
may have also have an effect: All-trans retinoic acid (ATRA) in
combination with SCF, FLT3L, IL-6, and IL-11-enriched
medium prolonged the repopulating capacity of HSCs [47]. The
Cu2+-chelator tetraethylenepentamine (TEPA) enhanced ex vivo
expansion of CD34+CD382 and CD34+ Lin2 subsets isolated
from umbilical cord blood samples, as well enhanced their short-
term repopulating activity in NOD-SCID mice [48]. The histon
deacetylase inhibitor (HDI) valproic acid [49] and StemRe-
genin1—a small molecule antagonist of the Aryl hydrocarbon
receptor [50]—were both able to promote long-term hematopoi-
esis following transplantation of cultured HSCs. Prostaglandin E2
(PGE2) may also be useful for ex vivo expansion of HSC [51,52].
Taken together, several factors can be utilized to optimize most
prominent ex vivo expansion conditions for HSCs.
The optimal mix of cytokines and culture conditions that
warrant most optimal ex vivo HSC expansion is not yet clear. We
therefore explored ex vivo expansion of HSCs using two different
combinations of growth factors (STF and STIF) with or without
the addition of Angptl3. Angptl3 may provide optimal preserva-
tion of stemness and promote long-term hematopoiesis without
provoking leukemogenic or toxic effects following transplantation.
The Angptl3 polypeptide (455 amino acids) has all the character-
istic features of angiopoietins, and includes a signal peptide, an
extended helical domain that forms dimeric or trimeric coiled
coils, a short linker peptide and a globular fibrinogen homology
domain (FHD). Angptl3 is expressed by BM-endothelial and other
stromal cells, and binds directly to the cell-surface on HSCs [27].
For this, HSCs have the immune-inhibitory receptor human
leukocyte immunoglobulin-like receptor B2 (LILRB2) that can
bind various ANGPTLs. In mice, the orthologue paired immu-
noglobulin-like receptor (PIRB) has also been identified as a
receptor for various Angptl proteins [28]. Binding of Angptl3 to
the receptors of HSCs provoke differences in the expression of cell
cycle regulators and transcription factors like repression of Ikaros
but upregulation of Hes1 and Hoxa9, which are both important
regulators for HSC self-renewal and differentiation [27]. Angptl3-
null mice were shown to have a 3-fold higher level of Ikaros [27].
Ectopic expression of Ikaros in mouse HSCs severely reduced
hematopoietic reconstitution capacity following transplantation
[27], which suggests that Angptl3 may be one of the most
important regulators for HSC stemness [27].
Incubation of HSCs in STF and STIF media has a similar effect
on the expansion of overall cell numbers as well as progenitors and
short-term HSC numbers. We now demonstrate that STIF is
superior over STF to preserve the total number of LSK cells,
resulting in improved long-term hematopoietic repopulation
results following transplantation. The addition of Angptl3 does
not change the overall expansion rate, but improves the
preservation of HSC stemness that support short-term and long-
term hematopoiesis. Culturing LSK cells in the presence of
STFA3 for 7 days improves short-term hematopoiesis in CFU-S
assays by ,40-fold compared to the control group. The long-term
repopulating capacity of LSK cells is enhanced ,32-fold following
a 7 days incubation in STIFA3 media as estimated from peripheral
blood erythrocyte chimerism levels. The effect of Angptl3 is clear
percentage of GFP positive cells was determined, 9 months after re-transplantation in BM, and spleen in an average of 5 mice per group. (C) Nine
months post transplantation, the percentage of different blood lineages (Sca-1, c-kit, Sca-1/c-kit, CD4, CD8, CD19, and CD11b cells) in donor-derived
cells (GFP+) in PB, (D) in BM, and (E) in spleen was measured by flow cytometry. *P#0.05.
doi:10.1371/journal.pone.0105642.g004
Figure 5. Angptl3 overexpression enhances the expansion of CFU-GM and ST-HSCs in vivo. Nine months post transplantation, two
thousands sorted BM Lin2 GFP+ cells of primary recipients (LV-GFP or LV-Angptl3-GFP groups) were plated in a semi-solid colony culture (n = 4). The
number of the (A) BFU-E and the (B) CFU-GM was quantified. The average numbers of colonies from 26103 plated cells were calculated from
quadruplicates. (C) One thousand sorted BM Lin2 GFP+ cells from primary recipients (LV-GFP or LV-Angptl3-GFP groups) were transplanted into
lethally irradiated mice (n = 7 mice per group). *P#0.05, and **P#0.01.
doi:10.1371/journal.pone.0105642.g005
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both on Lin2 cells as well as on highly purified HSCs (LSK-cells),
indicating that the effect of Angptl3 is directly on HSCs and
preserves stemness. In addition to a direct effect of Angptl3 on
stem cells, we observed that the repopulating capacity of long-term
hematopoiesis after transplantation was better for Lin2 cells than
for highly purified LSK cells, implying that Angptl3 may also exert
an additional effect on accessory cells that support the mainte-
nance of HSCs.
The effect of Angptl3 on preserving stemness of HSCs was
further supported by finding reduced numbers of circulating
CD19+ B-cells following transplantation of Angptl3-expressing
HSCs. As overexpression of Angptl3 down-regulates Ikaros in
HSCs [27], and since Ikaros deletions are frequently observed in
B-cell acute lymphoblastic leukemias [53], this may provide an
alternative explanation for the reduced circulating mature B-cells
following transplantation of Angptl3-overexpressing HSCs. In our
experiments, we did not find any evidence for leukemia or other
types of cancer or toxicity at nine months following transplantation
of Angptl3-overexpressing donor HSCs.
Conclusions
To conclude, we showed that the combination of five growth
factors [SCF, TPO, IGF-2, FGF-1 and Angptl3 (STIFA3)] yielded
a very significant expansion of stem cells that were able to provide
long-term hematopoiesis in mice. This combination may promote
superior engraftment over existing methods when using minimal
stem cell numbers in the case of genetically-modified HSCs to
treat genetic diseases or transplants that rely on umbilical cord
blood stem cell donors.
Supporting Information
Figure S1 Angptl3 promotes the expansion of HSCs in Lin2 cell
populations. Lin2 cells were cultured in STF, STFA3, STIF, or
STIFA3 medium for 10 days. (A) The mean fold increase in total
cell numbers was measured relative to day 0. The results of five
independent experiments are shown. The error bars indicate the
standard deviation (SD). * signifies P,0.05. (B, C) Colony
forming-units (BFU-E and CFU-GM) of Lin2 cells cultured for 4,
7 or 10 days relative to day 0. The results of 5 independent
experiments in duplicates are shown. (D) The CFU-S (12-day)
expansion of Lin2 cells cultured for 4 or 7 days in the presence of
4 distinct combinations of growth factors relative to day 0. The
results of two independent experiments are shown. N= 7 mice per
group.
(TIF)
Figure S2 Angptl3 stimulates the expansion of LT-HSCs in
Lin2 cell populations. (A) One thousand Lin2 cells (equivalent to
day 0), either fresh or cultured for 4, 7, or 10 days under STF or
STFA3 conditions were transplanted into sub lethally irradiated
recipients. The percentage of erythrocyte chimerism was deter-
mined 1 month and 6 months after transplantation. Five mice
were used per group. The error bars indicate the standard
deviation (SD). P-values equal or lower that p = 0.05 are marked
by an asterisks. (B) The percentage of leukocytes chimerism of
transplantation of 1000 Lin2 cells (equivalent to day 0), either
fresh or cultured for 7 days under STF or STFA3 conditions was
determined in bone marrow of recipients, 6 months after
retransplantation. N= 5 mice per group. (C) Serial dilution of
fresh Lin2 cells (3000 or 1000) or cultured cells (1000 or 300) for 7
days were transplanted into primary recipients. The data
represents erythrocyte chimerism of 3000, 1000, or 300 trans-
planted Lin2 cells after 6 months. N= 5 mice per group. The error
bars indicate the standard deviation.
(TIF)
Table S1 Angptl3 promotes the expansion of HSCs in Lin2 cell
populations, primary data. (A, B) Two thousands Lin2 cells fresh
or cultured in STF, STFA3, STIF, or STIFA3 medium were
plated in 35 mm culture dishes that contained 1 ml of enriched
DMEM culture medium that was supplemented with 0.8% (wt/
vol) methylcellulose. 2 weeks post plating, colonies were counted in
each dish. The experiments were performed in duplicates. The
result of colony forming-units (BFU-E and CFU-GM) of Lin2 cells
cultured for 4, 7 or 10 is presented as a mean of duplicates. The
results of five independent experiments are shown. (C) The CFU-S
(12-day) colony numbers of uncultured Lin2 cells (3000, 1000
cells) or cultured for 4 or 7 days (1000, 100) in the presence of 4
distinct combinations of growth factors. The results of two serial
dilution are shown. N= 7 mice per group.
(TIF)
Table S2 Angptl3 promotes the expansion of |HSCs in LSK cell
populations, primary data. Two hundred LSK cells were cultured
in STF, STFA3, STIF, or STIFA3 medium for 7 days were plated
in 35 mm culture dishes that contained 1 ml of enriched DMEM
culture medium that was supplemented with 0.8% (wt/vol)
methylcellulose. 2 weeks post plating, colonies were counted in
each dish. The experiments were performed in duplicates. The
results of 5 independent experiments are shown The result of
colony forming-units (BFU-E and CFU-GM) of LSK cells cultured
7 days is presented as a mean of duplicates. (A) Colony forming-
units of BFU-E and (B) CFU-GM. (D) The CFU-S (12-day) colony
numbers of transplanting 100 LSK cells fresh or cultured for 7
days in the presence of 4 distinct combinations of growth factors
12 days post transplantation into lethally irradiated mice. The
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